Kalvista Pharmaceuticals shares owned by UBS Group
Quarter-by-quarter ownership of Kalvista Pharmaceuticals (KALV) shares owned by UBS Group
from 13F filings
Historical chart of UBS Group investment in Kalvista Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Kalvista Pharmaceuticals held by UBS Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Kalvista Pharmaceuticals by UBS Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-12-31 | $3.2M | 375k | 8.47 |
| 2024-09-30 | $504k | 43k | 11.60 |
| 2024-06-30 | $158k | 13k | 11.80 |
| 2024-03-31 | $337k | 29k | 11.80 |
| 2023-12-31 | $331k | 27k | 12.20 |
| 2023-09-30 | $214k | 22k | 9.63 |
| 2023-06-30 | $143k | 16k | 9.00 |
| 2023-03-31 | $53k | 6.7k | 7.86 |
| 2022-12-31 | $65k | 9.6k | 6.76 |
| 2022-09-30 | $18k | 1.2k | 14.61 |
| 2022-06-30 | $10k | 1.1k | 9.40 |
| 2022-03-31 | $634k | 43k | 14.75 |
| 2021-12-31 | $708k | 54k | 13.22 |
| 2021-09-30 | $580k | 33k | 17.46 |
| 2021-06-30 | $104k | 4.3k | 24.06 |
| 2021-03-31 | $277k | 11k | 25.71 |
| 2020-12-31 | $34k | 1.8k | 19.22 |
| 2020-09-30 | $10k | 758 | 13.19 |
| 2020-06-30 | $52k | 4.3k | 12.05 |
| 2020-03-31 | $57k | 7.5k | 7.59 |
| 2019-12-31 | $310k | 17k | 17.82 |
| 2019-09-30 | $124k | 11k | 11.58 |
| 2019-06-30 | $47k | 2.1k | 22.32 |
| 2019-03-31 | $14k | 485 | 28.87 |
| 2018-09-30 | $14k | 660 | 20.55 |
| 2018-06-30 | $25k | 3.1k | 8.03 |
| 2018-03-31 | $1.0k | 145 | 6.90 |
| 2017-12-31 | $16k | 1.6k | 10.06 |
| 2017-06-30 | $11k | 1.5k | 7.30 |
| 2017-03-31 | $18k | 2.3k | 7.80 |
| 2016-12-31 | $6.0k | 909 | 6.60 |